However, CTSB inhibitor had a variable effect on the levels of FLI1 and ERG in cells treated with SSc serum with ERG being somewhat more responsive to the treatment than FLI1 (Figures 6D‐F and S1). This evidence concerns the gene CTSB and systemic sclerosis.